CRIS Current Research Information System

FIORINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.952
AS - Asia 5.212
EU - Europa 3.552
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 245
AF - Africa 143
OC - Oceania 5
Totale 15.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.825
SG - Singapore 1.530
IT - Italia 1.314
CN - Cina 1.243
VN - Vietnam 1.208
GB - Regno Unito 546
HK - Hong Kong 420
SE - Svezia 332
DE - Germania 328
BR - Brasile 240
FR - Francia 215
IN - India 185
RU - Federazione Russa 159
KR - Corea 146
IE - Irlanda 138
NL - Olanda 133
BD - Bangladesh 106
JP - Giappone 93
UA - Ucraina 85
JO - Giordania 75
CA - Canada 69
FI - Finlandia 65
ZA - Sudafrica 65
BG - Bulgaria 40
EE - Estonia 36
ID - Indonesia 33
ES - Italia 27
MX - Messico 25
AT - Austria 24
AR - Argentina 23
PH - Filippine 23
IQ - Iraq 22
TH - Thailandia 21
CI - Costa d'Avorio 20
TR - Turchia 20
CH - Svizzera 18
TW - Taiwan 18
BE - Belgio 17
EC - Ecuador 16
SC - Seychelles 15
MY - Malesia 13
PK - Pakistan 13
PL - Polonia 13
CO - Colombia 10
PY - Paraguay 10
GR - Grecia 8
HR - Croazia 8
JM - Giamaica 8
SA - Arabia Saudita 8
MA - Marocco 7
RO - Romania 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
EG - Egitto 6
TG - Togo 6
UZ - Uzbekistan 6
AL - Albania 5
AU - Australia 5
LB - Libano 5
RS - Serbia 5
DK - Danimarca 4
KE - Kenya 4
LK - Sri Lanka 4
LT - Lituania 4
PE - Perù 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
NI - Nicaragua 3
PT - Portogallo 3
SI - Slovenia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
ET - Etiopia 2
KZ - Kazakistan 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AI - Anguilla 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CD - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GD - Grenada 1
GH - Ghana 1
GN - Guinea 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
Totale 15.161
Salva come PNG Salva come JPEG
Città #
Singapore 1.047
Ashburn 556
Southend 455
Hong Kong 400
Hefei 328
Chandler 306
San Jose 301
Santa Clara 290
Ho Chi Minh City 285
Fairfield 277
Hanoi 241
Council Bluffs 178
Bologna 154
Woodbridge 151
Princeton 144
Beijing 141
Dublin 137
Seoul 134
Los Angeles 132
Wilmington 130
Houston 127
Dong Ket 125
Boardman 123
Milan 121
New York 121
Seattle 118
Cambridge 105
Ann Arbor 101
Lauterbourg 92
Dallas 79
Rome 78
Amman 75
Tokyo 68
Buffalo 56
Westminster 52
Da Nang 49
Helsinki 45
Jacksonville 45
Nanjing 45
Padova 45
Berlin 43
Redmond 40
Sofia 40
Jinan 37
Turin 36
San Francisco 35
São Paulo 35
Haiphong 33
Tappahannock 31
Bengaluru 30
Naples 30
Redondo Beach 30
Atlanta 29
Guangzhou 28
Chicago 25
Montreal 24
Shanghai 24
Parma 23
Des Moines 22
Frankfurt am Main 22
Phoenix 22
Shenyang 22
Biên Hòa 21
Denver 21
Orem 21
Abidjan 20
Brooklyn 20
Changsha 20
San Diego 19
Florence 18
London 18
Nuremberg 18
Munich 17
Rimini 17
Tianjin 17
Yubileyny 17
Bari 16
Brussels 16
Hebei 16
Jakarta 16
Moscow 16
Saint Petersburg 16
Johannesburg 15
Lappeenranta 14
Mülheim 14
Zhengzhou 14
Amsterdam 13
Dearborn 13
Hangzhou 13
Hải Dương 13
Modena 13
Nanchang 13
Verona 13
Shenzhen 12
Bangkok 11
Frattamaggiore 11
Madrid 11
Mexico City 11
Nakano 11
Norwalk 11
Totale 8.704
Salva come PNG Salva come JPEG
Nome #
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 612
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 610
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? 526
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 393
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study 342
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 272
In vivo dissolution of levothyroxine soft gel capsules 251
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 226
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 213
Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study. 207
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 202
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 197
Gastroesophageal Reflux Disease and Barrett’s Esophagus 191
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 185
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 185
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels 184
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 180
Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure 179
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 176
Therapy for H. pylori: Current concepts 172
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 170
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 170
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 170
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 167
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 165
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 164
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol 163
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 160
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 159
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 159
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 159
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 159
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 158
Probiotici ricombinanti e loro potenziale sulla salute umana 153
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 150
Diagnosi dell'infezione da Helicobacter pylori 150
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 147
Recombinant probiotics and their potential in human health 145
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 140
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 140
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 140
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 138
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 138
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 137
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 137
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 134
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients 134
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 132
Expanding Cancer Prevention: Strategies Integrated into Occupational Health Surveillance 129
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 129
Diagnostic yield of upper endoscopy according to appropriateness: A systematic review 129
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 128
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 127
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 127
Nephrotic Range Proteinuria and Acute Heart Failure 127
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 126
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 124
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 123
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 122
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 118
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 116
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 116
Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation 116
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 115
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 112
Role of Helicobacter Pylori Infection in the Thyroid Diseases 112
New strategies for the treatment of hyperkalemia. 109
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis 109
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 109
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 106
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 105
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale 104
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 103
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 103
Diverticulosis, Adenomas, and Cancer in the Colon A Systematic Review and Meta-Analysis of Endoscopic Studies 102
Sequential therapy for first-line helicobacter pylori eradication: 10- or 14-day regimen? 101
The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review 101
Whipple’s Disease: Case Report and Review of the Literature 99
Comparative Evaluation of Tongue and Periodontal Pocket Microbiome in Relation to Helicobacter pylori Gastric Disease: 16S rRNA Gene Sequencing Analysis 99
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 98
Understanding the epidemiology of gastric cancer: A review and case-only analysis from Italy 97
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 95
Newer agents for Helicobacter pylori eradication 93
Paradigm shift: The copernican revolution in diverticular disease 92
Rescue Therapies for H. pylori Infection in Italy 91
Helicobacter pylori: la nuova terapia. 89
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 84
null 83
Gestione del paziente, diagnostica rapida, nuove terapie per l’infezione da Helicobacter pylori. 83
null 81
Lung ultrasound in the COVID-19 era: a lesson to be learned for the future 79
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? 79
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 78
Helicobacter Pylori infection in psoriatic patients during biological therapy 77
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 75
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 75
Is the First Cut Always the Deepest? 74
Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study 73
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 71
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 69
Totale 15.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.080 0 40 58 123 125 44 27 86 42 31 333 171
2022/20231.375 118 140 89 160 77 110 55 92 314 70 93 57
2023/2024719 45 123 49 83 39 96 39 40 23 65 66 51
2024/20252.432 107 356 194 169 392 145 161 95 50 102 143 518
2025/20265.688 413 513 461 432 585 358 696 232 1.059 463 256 220
2026/20271.670 1.141 529 0 0 0 0 0 0 0 0 0 0
Totale 15.422